Health care costs of complex perianal fistula in Crohn's disease

Digestive Diseases and Sciences

Volumn 58, Issue 12, 2013, Pages 3400-3406

  Chaparro, M ^a,b   Zanotti, C ^c   Burgueno P ^a   Vera, I ^d   Bermejo, F ^e   Marin Jimenez I ^f   Yela, C ^g   Lopez P ^h   Martin M D ⁱ   Taxonera, C ^j   Botella, B ^k   Pajares, R ^l   Ponferrada, A ^m   Calvo, M ^d   Algaba, A ^e   Perez L ^f   Casis, B ^g   Mate J ^a,b   Orofino, J ^c   Lara, N ⁿ   Garcia Losa M ⁿ   Badia, X ⁿ   Gisbert, J P ^a,b   more..

^a Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Cellerix SA   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^h HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^j HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^k HOSPITAL INFANTA CRISTINA   (Spain)

^l HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^m HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

ⁿ IQVIA   (United States)

more..

Author keywords

Complex fistulas; Costs; Health resources; Perianal Crohn's disease

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; CIPROFLOXACIN; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; TACROLIMUS;

ABSCESS DRAINAGE; ADULT; ANESTHESIA; ANESTHESIST; ANORECTAL PRESSURE; ANUS FISTULA; ARTICLE; BLOOD ANALYSIS; BLOOD CULTURE; COLON SURGERY; COLONOSCOPY; COLOSTOMY; COMPLEX PERIANAL FISTULA; COMPUTER ASSISTED TOMOGRAPHY; COST OF ILLNESS; CROHN DISEASE; DERMATOLOGY; EMERGENCY WARD; FECES ANALYSIS; FEMALE; GASTROENTEROLOGIST; GASTROENTEROLOGY; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE PLANNING; HOSPITALIZATION; HUMAN; ILEOSTOMY; INTESTINE RESECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PERIANAL ABSCESS; POPULATION AND POPULATION RELATED PHENOMENA; PRIORITY JOURNAL; RECTOSCOPY; RECTUM RESECTION; RETROSPECTIVE STUDY; SIGMOIDECTOMY; SURGICAL SWAB; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADULT; COST OF ILLNESS; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; RECTAL FISTULA; RETROSPECTIVE STUDIES;

EID: 84890129949     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2830-7     Document Type: Article

References (24)

1. Jaisson-Hot I, Flourie B, Descos L, et al. Management for severe Crohn's disease: a lifetime cost-utility analysis. Int J Technol Assess Health Care. 2004;20:274-279.
2. Juan J, Estiarte R, Colome E, et al. Burden of illness of Crohn's disease in Spain. Dig Liver Dis. 2003;35:853-861.
3. Silverstein MD, Loftus EV, Sandborn WJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology. 1999;117:49-57.
4. Hay AR, Hay JW. Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol. 1992;14:318-327.
5. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol. 1992;14:309-317.
6. Feagan BG, Vreeland MG, Larson LR, et al. Annual cost of care for Crohn's disease: a payor perspective. Am J Gastroenterol. 2000;95:1955-1960.
7. Ingle SB, Loftus EV Jr. The natural history of perianal Crohn's disease. Dig Liver Dis. 2007;39:963-969.
8. Figg RE, Church JM. Perineal Crohn's disease: an indicator of poor prognosis and potential proctectomy. Dis Colon Rectum. 2009;52:646-650.
9. Cohen RD, Waters HC, Tang B, et al. Effects of fistula on healthcare costs and utilization for patients with Crohn's disease treated in a managed care environment. Inflamm Bowel Dis. 2008;14:1707-1714.
10. Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005;128:862-869.
11. Khaikin M, Chowers Y, Zmora O. Perianal Crohn's disease. Isr Med Assoc J. 2007;9:163-168.
12. Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. 2007;132:52-65.
13. Bell SJ, Williams AB, Wiesel P, et al. The clinical course of fistulating Crohn's disease. Aliment Pharmacol Ther. 2003;17:1145-1151.
14. Bodger K. Cost of illness of Crohn's disease. Pharmacoeconomics. 2002;20:639-652.
15. Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol. 1997;32:1134-1139.
16. Saro C, De la Coba C, Casado MA, et al. Resource use in patients with Crohn's disease treated with infliximab. Aliment Pharmacol Ther. 2007;26:1313-1323.
17. www.oblikue.com/bddcostes.
18. Bot PLUS. Base de datos del conocimiento sanitario (CD-ROM). Madrid: Consejo General de Colegios Oficiales de Farmaceúticos; 2010.
19. Arseneau KO, Cohn SM, Cominelli F, et al. Cost-utility of initial medical management for Crohn's disease perianal fistulae. Gastroenterology. 2001;120:1640-1656.
20. Rubenstein JH, Chong RY, Cohen RD. Infliximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol. 2002;35:151-156.
21. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350:876-885.
22. Jewell DP, Satsangi J, Lobo A, et al. Infliximab use in Crohn's disease: impact on health care resources in the UK. Eur J Gastroenterol Hepatol. 2005;17:1047-1052.
23. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum. 2002;45:771-775.
24. Domènech E, Hinojosa J, Nos P, et al. Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated? Aliment Pharmacol Ther. 2005;22:1107-1113.